Sterile inflammation in the liver
- PMID: 22982943
- DOI: 10.1053/j.gastro.2012.09.008
Sterile inflammation in the liver
Abstract
Inflammation In the absence of pathogens occurs in all tissues in response to a wide range of stimuli that cause tissue stress and injury. Such sterile inflammation (SI) is a key process in drug-induced liver injury, nonalcoholic steatohepatitis, and alcoholic steatohepatitis and is a major determinant of fibrosis and carcinogenesis. In SI, endogenous damage-associated molecular patterns (DAMPS), which are usually hidden from the extracellular environment, are released on tissue injury and activate receptors on immune cells. More than 20 such DAMPS have been identified and activate cellular pattern recognition receptors, which were originally identified as sensors of pathogen-associated molecular patterns. Activation of pattern recognition receptors by DAMPS results in a wide range of immune responses, including production of proinflammatory cytokines and localization of immune cells to the site of injury. DAMPS result in the assembly of a cytosolic protein complex termed the inflammasome, which activates the serine protease caspase-1, resulting in activation and secretion of interleukin-1β and other cytokines. SI-driven liver diseases are responsible for the majority of liver pathology in industrially developed countries and lack specific therapy. Identification of DAMPS, their receptors, signaling pathways, and cytokines now provides a wide range of therapeutic _targets for which many antagonists are already available.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Inflammasome activation and function in liver disease.Nat Rev Gastroenterol Hepatol. 2015 Jul;12(7):387-400. doi: 10.1038/nrgastro.2015.94. Epub 2015 Jun 9. Nat Rev Gastroenterol Hepatol. 2015. PMID: 26055245 Review.
-
The contribution of sterile inflammation to the fatty liver disease and the potential therapies.Biomed Pharmacother. 2022 Apr;148:112789. doi: 10.1016/j.biopha.2022.112789. Epub 2022 Mar 7. Biomed Pharmacother. 2022. PMID: 35272137 Review.
-
The inflammasome in liver injury and non-alcoholic fatty liver disease.Dig Dis. 2014;32(5):507-15. doi: 10.1159/000360495. Epub 2014 Jul 14. Dig Dis. 2014. PMID: 25034283 Review.
-
Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice.J Hepatol. 2015 Nov;63(5):1147-55. doi: 10.1016/j.jhep.2015.06.013. Epub 2015 Jun 20. J Hepatol. 2015. PMID: 26100496 Free PMC article.
-
DAMPs and sterile inflammation in drug hepatotoxicity.Hepatol Int. 2019 Jan;13(1):42-50. doi: 10.1007/s12072-018-9911-9. Epub 2018 Nov 24. Hepatol Int. 2019. PMID: 30474802 Review.
Cited by
-
Therapeutic potential of interleukin 1 inhibitors in the treatment of alcoholic liver disease.Hepatology. 2013 May;57(5):2078-80. doi: 10.1002/hep.26336. Hepatology. 2013. PMID: 23609413 Free PMC article.
-
The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease.Orphanet J Rare Dis. 2020 Jul 2;15(1):173. doi: 10.1186/s13023-020-01452-2. Orphanet J Rare Dis. 2020. PMID: 32615997 Free PMC article.
-
P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis.J Clin Transl Hepatol. 2022 Dec 28;10(6):1205-1212. doi: 10.14218/JCTH.2022.00022. Epub 2022 May 17. J Clin Transl Hepatol. 2022. PMID: 36381094 Free PMC article. Review.
-
Obesity-associated Airway Hyperresponsiveness: Mechanisms Underlying Inflammatory Markers and Possible Pharmacological Interventions.Endocr Metab Immune Disord Drug _targets. 2024;24(9):1053-1068. doi: 10.2174/0118715303256440231028072049. Endocr Metab Immune Disord Drug _targets. 2024. PMID: 37957906 Review.
-
Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab _targeting EpCAM, CD3 and Fcγ receptors.Onco_target. 2016 May 10;7(19):28059-74. doi: 10.18632/onco_target.8574. Onco_target. 2016. PMID: 27058902 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical